Literature DB >> 24818301

Medicare and Medicaid programs; regulatory provisions to promote program efficiency, transparency, and burden reduction; Part II.

.   

Abstract

This final rule reforms Medicare regulations that CMS has identified as unnecessary, obsolete, or excessively burdensome on health care providers and suppliers, as well as certain regulations under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). This final rule also increases the ability of health care professionals to devote resources to improving patient care, by eliminating or reducing requirements that impede quality patient care or that divert resources away from providing high quality patient care. We are issuing this rule to achieve regulatory reforms under Executive Order 13563 on improving regulation and regulatory review and the Department's plan for retrospective review of existing rules. This is the latest in a series of rules developed by CMS over the last 5 years to reform existing rules to reduce unnecessary costs and increase flexibility for health care providers.

Entities:  

Mesh:

Year:  2014        PMID: 24818301

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  3 in total

1.  Association of transplant center market concentration and local organ availability with deceased donor kidney utilization.

Authors:  Syed A Husain; Kristen L King; David C Cron; Nikole A Neidlinger; Han Ng; Sumit Mohan; Joel T Adler
Journal:  Am J Transplant       Date:  2022-03-07       Impact factor: 9.369

2.  The Advancing American Kidney Health (AAKH) Executive Order: Promise and Caveats for Expanding Access to Kidney Transplantation.

Authors:  Krista L Lentine; Roslyn B Mannon
Journal:  Kidney360       Date:  2020-06

3.  Impact of Extending Eligibility for Reinstatement of Waiting Time After Early Allograft Failure: A Decision Analysis.

Authors:  S Ali Husain; Kristen L King; Joel T Adler; Sumit Mohan; Rimma Perotte
Journal:  Am J Kidney Dis       Date:  2021-09-22       Impact factor: 8.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.